• About
    • Login
    View Item 
    •   Institutional Repository Home
    • Electronic Theses and Dissertations
    • Electronic Theses and Dissertations
    • View Item
    •   Institutional Repository Home
    • Electronic Theses and Dissertations
    • Electronic Theses and Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of Institutional RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Optical Metabolic Imaging to Characterize Early Treatment Response in Head and Neck Cancer

    Shah, Amy Trushar
    : https://etd.library.vanderbilt.edu/etd-06032016-130255
    http://hdl.handle.net/1803/12463
    : 2016-06-06

    Abstract

    Optimized therapies and methods to resolve treatment response could improve quality of life and survival for head and neck cancer patients. Optical metabolic imaging presents an advantageous method to address these needs by measuring intrinsic fluorescence from the metabolic cofactors NAD(P)H and FAD and calculating the optical redox ratio and fluorescence lifetimes of NAD(P)H and FAD. These parameters probe global cell metabolism as well as molecular protein-binding in metabolic signaling pathways. This dissertation work measures treatment response (p<0.05) by applying optical metabolic imaging to head and neck cancer in vitro and in vivo within 2 days of treatment with targeted therapies, chemotherapy, and drug combination. These measurements are characterized in established cell lines, head and neck cancer xenografts, human patient tissue, and three-dimensional organoid cultures. Gold standard measures validate treatment response, including cell proliferation, cell death, and tumor growth over 2 weeks of treatment. Additionally, high-resolution optical metabolic images qualitatively and quantitatively characterize cellular heterogeneity, which can impact patient response or resistance to treatment. Clinically, optical metabolic imaging could measure early response to treatment in head and neck cancer patients, thereby enabling intervention and reduced toxicities from ineffective therapies. Additionally, optical metabolic imaging could provide a platform to streamline drug discovery for head and neck cancer and predict personalized treatment regimens for patients.
    Show full item record

    Files in this item

    Icon
    Name:
    Shah.pdf
    Size:
    5.405Mb
    Format:
    PDF
    View/Open

    This item appears in the following collection(s):

    • Electronic Theses and Dissertations

    Connect with Vanderbilt Libraries

    Your Vanderbilt

    • Alumni
    • Current Students
    • Faculty & Staff
    • International Students
    • Media
    • Parents & Family
    • Prospective Students
    • Researchers
    • Sports Fans
    • Visitors & Neighbors

    Support the Jean and Alexander Heard Libraries

    Support the Library...Give Now

    Gifts to the Libraries support the learning and research needs of the entire Vanderbilt community. Learn more about giving to the Libraries.

    Become a Friend of the Libraries

    Quick Links

    • Hours
    • About
    • Employment
    • Staff Directory
    • Accessibility Services
    • Contact
    • Vanderbilt Home
    • Privacy Policy